Partnership Aims to Enhance the Availability of Advanced Genetic Analysis Technologies Developed by Nonacus in Japan
Taipei, Taiwan – June 21, 2024
Advanced Genomics APAC Co. Ltd. is pleased to announce the signing of a distribution agreement with FINGGAL LINK CO., LTD., a leading medical technology company based in Tokyo, Japan. This partnership will facilitate the distribution of cutting-edge genetic analysis solutions developed by Nonacus, a subsidiary of Advanced Genomics Limited (UK), across Japan.
FINGGAL LINK CO., LTD., located in Taito-ku, Tokyo, and led by President Masaaki Nagone, is renowned for its expertise in developing and selling innovative medical devices. The company has a strong presence in the Japanese market, providing advanced solutions to medical and nursing care facilities.
This partnership will leverage FINGGAL LINK's extensive distribution network and Advanced Genomics APAC's state-of-the-art genetic analysis technologies, developed by Nonacus, to meet the growing demand for accurate and efficient analysis tools in Japan. The agreement includes the distribution of Nonacus's flagship products, including the GALEAS series, which encompasses "GALEAS Tumor" and "GALEAS Bladder."
The collaboration aims to provide comprehensive genetic analysis solutions developed by Nonacus that enable precise identification of genetic mutations, facilitating early detection and personalized treatment strategies for various medical conditions. By integrating Advanced Genomics APAC's technologies with FINGGAL LINK's robust distribution capabilities, both companies are poised to make significant strides in advancing cancer research and enhancing the future of diagnostics in Japan.
About Advanced Genomics APAC
Advanced Genomics APAC Co. Ltd. provides cutting-edge genetic testing solutions across the Asia-Pacific region. As a subsidiary of Advanced Genomics Limited (UK), the company focuses on innovation and excellence to meet the rising demand for genetic testing services, enhance early cancer detection, and strengthen the accuracy of cancer diagnostics through strategic partnerships and advanced technology.
About Nonacus
Nonacus, a subsidiary of Advanced Genomics Limited (UK), specializes in the development of advanced genetic analysis products. The company is committed to providing innovative solutions that enhance early detection and personalized treatment of various medical conditions.
About FINGGAL LINK CO., LTD.
FINGGAL LINK CO., LTD., established in 1990 and headquartered in Taito-ku, Tokyo, specializes in the development and sales of medical equipment. The company is known for its user-friendly device support systems and innovative solutions.
Contact Information
For media inquiries, please contact:
Advanced Genomics APAC
Phone: +886-3-2870503
Email: infoapac@nonacus.com
Comentarios